🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

74+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 74 recruiting trials for “sickle-cell-s-d-punjab-disease

NARecruitingNCT06511453

Acupressure in Patients With Sickle Cell Disease

🏥 Indiana University📍 2 sites📅 Started Mar 2024View details ↗
NARecruitingNCT06074198

Sickle Cell Children's Exercise Study (SuCCESs)

🏥 University of Maryland, Baltimore📍 2 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05953584

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

👨‍⚕️ Clinical Transparency (dept. 2834), Novo Nordisk A/S📍 9 sites📅 Started Jun 2023View details ↗
Phase 4RecruitingNCT05730205

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

🏥 University of Pennsylvania📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT06385886

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

👨‍⚕️ Julie Kanter, MD, University of Alabama, Birmingham (UAB)📍 9 sites📅 Started Jun 2023View details ↗
RecruitingNCT05810181

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

👨‍⚕️ Liza-Marie Johnson, MD, MPH, MSB, St. Jude Children's Research Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05640271

Tocilizumab for Acute Chest Syndrome

👨‍⚕️ Austin Wesevich, MD, University of Chicago📍 1 site📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05392894

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

👨‍⚕️ Ann-Marie Murtagh, King's College Hospitals NHS Foundation Trust📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05736419

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

👨‍⚕️ Maria Cancio, MD, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Feb 2023View details ↗
RecruitingNCT05748717

Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease

🏥 The University of The West Indies📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT06198712

A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

👨‍⚕️ Clinical Transparency (dept. 2834), Novo Nordisk A/S📍 18 sites📅 Started Jan 2023View details ↗
Phase 1RecruitingNCT04925492

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

👨‍⚕️ Enrico Novelli, MD, MS, University of Pittsburgh📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT05799118

Study of the Role of Genetic Modifiers in Hemoglobinopathies

👨‍⚕️ Petros Kountouris, PhD, Cyprus Institute of Neurology and Genetics📍 26 sites📅 Started Oct 2022View details ↗
RecruitingNCT05153967

Cooperative Assessment of Late Effects for SCD Curative Therapies

👨‍⚕️ Michael R DeBaun, MD, MPH, Vanderbilt University Medical Center📍 5 sites📅 Started Jul 2022View details ↗
Phase 2RecruitingNCT05336201

Cognitive Remediation Intervention to Prepare for Transition of Care

🏥 University of Alabama at Birmingham📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05170412

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

👨‍⚕️ Nicole M Farmer, M.D., National Institutes of Health Clinical Center (CC)📍 1 site📅 Started May 2022View details ↗
NARecruitingNCT05210114

Cutaneous Hydration Assessment in SCD

👨‍⚕️ Enrico Novelli, MD, University of Pittsburgh📍 1 site📅 Started Jan 2022View details ↗
RecruitingNCT06213402

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

👨‍⚕️ María del Mar Manú Pereira, PhD, Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH)📍 1 site📅 Started Nov 2021View details ↗
Phase 2RecruitingNCT05012631

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

🏥 Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Sep 2021View details ↗
NARecruitingNCT04484272

A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease

👨‍⚕️ Miriam O. Ezenwa, University of Florida📍 1 site📅 Started Apr 2021View details ↗
← PreviousPage 3 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →